Drug – bio-affecting and body treating compositions – Enzyme or coenzyme containing – Hydrolases
Patent
1988-02-22
1991-02-12
Schwartz, Richard A.
Drug, bio-affecting and body treating compositions
Enzyme or coenzyme containing
Hydrolases
424 9464, 435215, 435212, A61K 37547, C12N 972, C12N 948
Patent
active
049922742
ABSTRACT:
A fibrinolytically active hybrid protein which comprises one chain of a 2-chain protease linked to a chain of a different 2-chain protease, or to the same chain of the same protease, at least one of the chains in the hybrid protein being derived from a fibrinolytically active protease, such that the hybrid protein has a catalytic site essential for fibrinolytic activity which is optionally blocked by a removable blocking group.
REFERENCES:
patent: 4082612 (1978-04-01), Robbins et al.
patent: 4507283 (1985-03-01), Smith
patent: 4545988 (1985-10-01), Nakayama et al.
patent: 4600580 (1986-07-01), Smith
Summaria et al., J. Biol. Chem., vol. 254, pp. 6811-6814, 1979.
Robbins et al., Biochemistry, vol. 25, pp. 3603-3611, Jun., 1986.
Jackson et al., Biochem., 1982, 21, 6620-6625.
Summaria et al., J. Biol. Chem. 251, No. 18, 5810-5813 (1976).
Dodd Ian
Robinson Jeffery H.
Beecham Group p.l.c.
Porta Marianne
Schwartz Richard A.
LandOfFree
Tissue plasminogen activator A-chain/urokinase B-chain hybrid pr does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tissue plasminogen activator A-chain/urokinase B-chain hybrid pr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tissue plasminogen activator A-chain/urokinase B-chain hybrid pr will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-19568